Browse publications by year: 2017

  1. Maakip I, Oakman J, Stuckey R
    J Occup Rehabil, 2017 Jun;27(2):228-238.
    PMID: 27339144 DOI: 10.1007/s10926-016-9650-5
    Purpose Workers with musculoskeletal pain (MSP) often continue to work despite their condition. Understanding the factors that enable them to remain at work provides insights into the development of appropriate workplace accommodations. This qualitative study aims to explore the strategies utilised by female Malaysian office workers with MSP to maintain productive employment. Methods A qualitative approach using thematic analysis was used. Individual semi-structured interviews were conducted with 13 female Malaysian office workers with MSP. Initial codes were identified and refined through iterative discussion to further develop the emerging codes and modify the coding framework. A further stage of coding was undertaken to eliminate redundant codes and establish analytic connections between distinct themes. Results Two major themes were identified: managing the demands of work and maintaining employment with persistent musculoskeletal pain. Participants reported developing strategies to assist them to remain at work, but most focused on individually initiated adaptations or peer support, rather than systemic changes to work systems or practices. A combination of the patriarchal and hierarchical cultural occupational context emerged as a critical factor in the finding of individual or peer based adaptations rather than organizational accommodations. Conclusions It is recommended that supervisors be educated in the benefits of maintaining and retaining employees with MSP, and encouraged to challenge cultural norms and develop appropriate flexible workplace accommodations through consultation and negotiation with these workers.
    MeSH terms: Adaptation, Psychological; Adult; Cultural Characteristics; Employment/organization & administration; Employment/psychology*; Female; Humans; Interviews as Topic; Malaysia; Middle Aged; Sex Factors; Social Support; Women, Working/psychology*; Workplace/organization & administration*; Disclosure; Qualitative Research; Chronic Pain/psychology; Musculoskeletal Pain/psychology*
  2. Lim CT, Thevandran TK
    Clin Exp Nephrol, 2017 Apr;21(2):352-353.
    PMID: 27339441 DOI: 10.1007/s10157-016-1292-6
    MeSH terms: Biopsy; Female; Humans; Hyperparathyroidism, Secondary/diagnosis; Hyperparathyroidism, Secondary/etiology; Hyperparathyroidism, Secondary/surgery*; Jaw Diseases/diagnosis; Jaw Diseases/etiology*; Kidney Failure, Chronic/complications; Kidney Failure, Chronic/diagnosis; Kidney Failure, Chronic/therapy*; Osteitis Fibrosa Cystica/diagnosis; Osteitis Fibrosa Cystica/etiology*; Peritoneal Dialysis/adverse effects*; Parathyroidectomy*; Treatment Outcome; Young Adult
  3. Isah AA, Mahat NA, Jamalis J, Attan N, Zakaria II, Huyop F, et al.
    Prep Biochem Biotechnol, 2017 Feb 07;47(2):199-210.
    PMID: 27341522 DOI: 10.1080/10826068.2016.1201681
    The chemical route of producing geranyl propionate involves the use of toxic chemicals, liberation of unwanted by-products as well as problematic separation process. In view of such problems, the use of Rhizomucor miehei lipase (RML) covalently bound onto activated chitosan-graphene oxide (RML-CS/GO) support is suggested. Following analyses using Fourier transform infrared spectroscopy, field emission scanning electron microscopy, transmission electron microscopy, and thermogravimetry, properties of the RML-CS/GO were characterized. A response surface methodological approach using a 3-level-four-factor (incubation time, temperature, substrate molar ratio, and stirring rate) Box-Behnken design was used to optimize the experimental conditions to maximize the yield of geranyl propionate. Results revealed that 76 ± 0.02% of recovered protein had yielded 7.2 ± 0.04 mg g(-1) and 211 ± 0.3% U g(-1) of the maximum protein loading and esterification activity, respectively. The actual yield of geranyl propionate (49.46%) closely agreed with the predicted value (49.97%) under optimum reaction conditions (temperature: 37.67°C, incubation time: 10.20 hr, molar ratio (propionic acid:geraniol): 1:3.28, and stirring rate: 100.70 rpm) and hence, verifying the suitability of this approach. Since the method is performed under mild conditions, the RML-CS/GO biocatalyst may prove to be an environmentally benign alternative for producing satisfactory yield of geranyl propionate.
    MeSH terms: Culture Media; Enzymes, Immobilized/chemistry*; Graphite/chemistry*; Lipase/chemistry*; Microscopy, Electron, Scanning; Oxides/chemistry; Propionates/chemical synthesis*; Solvents; Rhizomucor/enzymology*; Microscopy, Electron, Transmission; Chitosan/chemistry*
External Links